The Landscape of Laboratory Corruption
How widespread is corruption in the lab—and what can be done to combat it?
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
How widespread is corruption in the lab—and what can be done to combat it?
What clinical validation really means—and why every member of the laboratory should understand it.
Audits can be helpful not just for compliance purposes, but for maximizing reimbursement and maintaining a healthy business.
G2’s list of major FDA approvals includes cancer and liquid biopsy, COVID-19, STI, and neurologic tests.
Recent cases involve Medicare’s 14-Day Rule, improper PHI disclosure to a media outlet, kickbacks, and COVID-19 fraud.
Comments on the FDA’s proposed rule to regulate LDTs as in vitro diagnostic devices reveal mixed reactions.
Genialis CEO and co-founder Rafael Rosengarten, PhD, discusses key 2023 AI developments and what they could mean for laboratories.
Five strategies for lab leaders to focus on to tackle the challenges of today and ensure future success.
Standard 1910.1450 requires labs to have a chemical hygiene plan.
Approaching laboratory safety from a diversity, equity, inclusion, and accessibility perspective.
With US STI cases continuing to climb to numbers not seen in decades, a recent FDA approval comes at an opportune moment.